Insider · CIK 0001631262

Marrazzo Jeffrey D

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001631262

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−92K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+92K sh	—	—	92,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−250K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-06-04	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2025-05-19	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+800K sh	—	—	800,000
2024-06-12	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-02-29	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2023-05-10	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+92K sh	—	—	92,000
2019-12-17	Spark Therapeutics, Inc.U Disposition from Tender	Director, CHIEF EXECUTIVE OFFICER	UDisposition from Tender	−355K sh	$114.50	−$40.7M	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−98K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−52.5K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−70K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−135K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−125K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−126K sh	—	—	0
2019-12-17	Spark Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, CHIEF EXECUTIVE OFFICER	DDisposition to Issuer	−49.3K sh	—	—	0
2019-03-15	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+49.9K sh	$3.45	+$172K	355,215
2019-03-15	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−49.9K sh	—	—	126,131
2019-01-18	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+5,000 sh	—	—	304,354
2019-01-18	Spark Therapeutics, Inc.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−1,655 sh	$45.08	−$74.6K	302,699
2019-01-18	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+3,750 sh	—	—	306,449
2019-01-18	Spark Therapeutics, Inc.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−1,174 sh	$45.08	−$52.9K	305,275
2019-01-18	Spark Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−5,000 sh	—	—	10,000
2019-01-18	Spark Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−3,750 sh	—	—	11,250
2019-01-15	Spark Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+98K sh	—	—	98,000
2019-01-15	Spark Therapeutics, Inc.Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+28K sh	—	—	28,000
2018-12-28	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+6,000 sh	$3.45	+$20.7K	299,354
2018-12-28	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−6,000 sh	—	—	176,071
2018-01-18	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+5,000 sh	—	—	295,000
2018-01-18	Spark Therapeutics, Inc.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−1,646 sh	$50.55	−$83.2K	293,354
2018-01-18	Spark Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+52.5K sh	—	—	52,500
2018-01-18	Spark Therapeutics, Inc.Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+15K sh	—	—	15,000
2018-01-18	Spark Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−5,000 sh	—	—	15,000
2017-12-19	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+60K sh	$3.45	+$207K	290,000
2017-12-19	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−60K sh	—	—	182,071
2017-11-13	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+20K sh	$3.45	+$69K	250,000
2017-11-13	Spark Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−20K sh	$71.54	−$1.43M	230,000
2017-11-13	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−20K sh	—	—	242,071
2017-08-23	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+21.4K sh	$3.45	+$73.7K	251,350
2017-08-23	Spark Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−21.4K sh	$80.01	−$1.71M	230,000
2017-08-23	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−21.4K sh	—	—	262,071
2017-08-11	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15K sh	$3.45	+$51.8K	245,000
2017-08-11	Spark Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−15K sh	$75.10	−$1.13M	230,000
2017-08-11	Spark Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15K sh	—	—	283,421
2017-08-02	Spark Therapeutics, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+28.7K sh	$3.45	+$98.8K	258,650
2017-08-02	Spark Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−28.7K sh	$80.01	−$2.29M	230,000

Recent filings

Accepted (ET)
Jun 84
Marrazzo Jeffrey D0001628280-26-041575
SEC(opens sec.gov)
Aug 54
Marrazzo Jeffrey D0001894562-25-000048
SEC(opens sec.gov)
Jun 54
Marrazzo Jeffrey D0001628280-25-029773
SEC(opens sec.gov)
May 194
Marrazzo Jeffrey D0001894562-25-000024
SEC(opens sec.gov)
Jun 144
Marrazzo Jeffrey D0001894562-24-000041
SEC(opens sec.gov)
Mar 44
Marrazzo Jeffrey D0001894562-24-000018
SEC(opens sec.gov)
May 124
Marrazzo Jeffrey D0001894562-23-000014
SEC(opens sec.gov)
Dec 174
Marrazzo Jeffrey D0000899243-19-029435
SEC(opens sec.gov)

Companies

Address

C/O PRIME MEDICINE, INC. 60 FIRST STREET

CAMBRIDGE, MA, 02141